logo

Otonomy Inc. (OTIC)



Trade OTIC now with
  Date
  Headline
8/19/2021 7:57:29 AM Otonomy Appoints Jill Broadfoot To Board
6/15/2021 7:39:26 AM Otonomy Begins Expansion Study For Phase 1/2 Clinical Trial Of OTO-413
12/17/2020 7:20:07 AM Otonomy Announces Positive Top-line Results From Phase 1/2 Clinical Trial Of OTO-413
11/30/2020 7:55:45 AM Otonomy Provides Updates Regarding Statistical Analysis Plan For Ongoing Phase 3 Trial Of OTIVIDEX
7/9/2020 9:13:43 AM Otonomy Prices Public Offering Of 14.50 Mln Shares At $3.25 Per Share
5/7/2020 7:50:58 AM Otonomy Q1 Loss/Shr $0.38 Vs Loss $0.39 Last Year
4/9/2020 7:39:47 AM Otonomy Provides Business Update Related To COVID-19; Still Sees FY Non-GAAP Operating Expenses Of $35-$38 Mln
1/28/2020 7:35:58 AM Otonomy Presents Preclinical Results For GJB2 Gene Therapy Collaboration And Cisplatin Otoprotection Program